The Coherex FlatStent: an advance in patent foramen ovale closure.

about

The Coherex FlatStent: an advance in patent foramen ovale closure.

Item

http://www.wikidata.org/entity/Q50560800

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh-hant

name

The Coherex FlatStent: an advance in patent foramen ovale closure.

@en

The Coherex FlatStent: an advance in patent foramen ovale closure.

@nl

type

Item

label

The Coherex FlatStent: an advance in patent foramen ovale closure.

@en

The Coherex FlatStent: an advance in patent foramen ovale closure.

@nl

prefLabel

The Coherex FlatStent: an advance in patent foramen ovale closure.

@en

The Coherex FlatStent: an advance in patent foramen ovale closure.

@nl

P1476

The Coherex FlatStent: an advance in patent foramen ovale closure.

@en

P2093

Peter N Ruygrok

http://www.w3.org/2001/XMLSchema#string

P2860

Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both

Patent foramen ovale: a review of associated conditions and the impact of physiological size.

Prevalence and size of directly detected patent foramen ovale in migraine with aura.

Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.

The incidence of patent foramen ovale in 1,000 consecutive patients. A contrast transesophageal echocardiography study.

Percutaneous closure of patent foramen ovale: impact of device design on safety and efficacy.

Patent foramen ovale and the platypnea-orthodeoxia syndrome.

Migraine headache relief after transcatheter closure of patent foramen ovale.

BioSTAR Evaluation STudy (BEST): a prospective, multicenter, phase I clinical trial to evaluate the feasibility, efficacy, and safety of the BioSTAR bioabsorbable septal repair implant for the closure of atrial-level shunts.

Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events.

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ERD.09.72

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20214425

http://www.w3.org/2001/XMLSchema#string